Europe drug regulator backs use of Moderna's COVID-19 booster vaccine

The European Union's drug regulator on Monday said it has concluded in its review that Moderna's COVID-19 booster vaccine may be given to people aged 18 years and above, at least six months after the second dose.

It is the second COVID-19 booster vaccine to be approved in the EU.

"This follows data showing that a third dose of Spikevax given 6 to 8 months after the second dose led to a rise in antibody levels in adults whose antibody levels were waning," the European Medicines Agency (EMA) said.